PTI-428 Uses, Dosage, Side Effects and more
PTI-428 is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy).
| Trade Name | PTI-428 |
| Generic | PTI-428 |
| Type | |
| Formula | C18H18N4O4 |
| Weight | Average: 354.366 Monoisotopic: 354.132805076 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
